Results 11 to 20 of about 76,067 (230)

Evaluation of the immune response of dogs after a mass vaccination campaign against rabies in Tunisia

open access: yesBMC Veterinary Research, 2023
Background Rabies (RABV) is an enzootic disease in Tunisia, with dogs being the primary reservoir. Vaccinating dogs is the key to eradicate rabies. Regional Veterinary Services conduct nationwide immunisation campaigns on an annual basis.
Mariem Handous   +8 more
doaj   +1 more source

Developments in Rabies Vaccines: The Path Traversed from Pasteur to the Modern Era of Immunization

open access: yesVaccines, 2023
Rabies is a disease of antiquity and has a history spanning millennia ever since the first interactions between humans and dogs. The alarming fatalities caused by this disease have triggered rabies prevention strategies since the first century BC.
Krithiga Natesan   +5 more
doaj   +1 more source

Monoclonal antibodies against rabies: current uses in prophylaxis and in therapy.

open access: yesCurrent Opinion in Virology, 2022
Rabies is a severe viral infection that causes an acute encephalomyelitis, which presents a case fatality of nearly 100% after the manifestation of neurological clinical signs.
G. D. de Melo   +4 more
semanticscholar   +1 more source

Assessment of Immune Responses to Rabies Vaccination in Free-Ranging Dogs in Bengaluru, India

open access: yesVaccines, 2023
Rabies is a fatal encephalomyelitis mainly transmitted to humans and other animals by rabid dog bites. Hence, vaccination programs are being instituted for the control of rabies in dogs.
Vinay Chavan Prakash Rao   +10 more
doaj   +1 more source

United Against Rabies Forum: The One Health Concept at Work

open access: yesFrontiers in Public Health, 2022
Human deaths from rabies are preventable and can be eliminated by applying a systematic One Health approach. However, this ancient disease still threatens the lives of millions of people in up to 150 countries and kills an estimated 59, 000 people every ...
R. Tidman   +15 more
semanticscholar   +1 more source

Rabies surveillance in the United States during 2020.

open access: yesJournal of the American Veterinary Medical Association, 2022
OBJECTIVE To provide epidemiological information on animal and human cases of rabies in the US during 2020 and summaries of 2020 rabies surveillance for Canada and Mexico.
Xiaoyue Ma   +12 more
semanticscholar   +1 more source

Pharmacokinetics and Efficacy of a Potential Smallpox Therapeutic, Brincidofovir, in a Lethal Monkeypox Virus Animal Model

open access: yesmSphere, 2021
Preparedness activities against highly transmissible viruses with high mortality rates have been highlighted during the ongoing coronavirus disease 2019 (COVID-19) pandemic.
Christina L. Hutson   +14 more
doaj   +1 more source

Advances in the progress of monoclonal antibodies for rabies

open access: yesHuman Vaccines & Immunotherapeutics, 2022
Rabies is a highly fatal zoonotic disease caused by the rabies virus invading the central nervous system. When suspected of exposure to the rabies virus, post-exposure prophylaxis should be administered as soon as possible.
Linlin Fan   +3 more
semanticscholar   +1 more source

Rabies

open access: yesVeterinary Clinics of North America: Equine Practice, 1997
Equine rabies is a sporadic but highly fatal zoonotic disease. The disease persists in wildlife populations throughout the United States, Canada, Mexico, and other parts of the world. It remains a threat to all domestic species, including the horse. This article reports recent advances in the molecular virology of the rabies virus and its pathogenesis,
T, Hemachudha, P, Phuapradit
openaire   +4 more sources

Rabies control in South Asia requires a One Health approach

open access: yesOne Health, 2021
Rabies is a vaccine-preventable viral disease present in more than 150 countries around the world. Globally, almost 60,000 people die each year from rabies, of which more than 58% are in Asia and around 45% in South Asia with especially high incidence in
K. P. Acharya, D. Subedi, R. Wilson
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy